Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Secures Funding for Regulatory Submissions of its Alzheimer's Treatment

Stock Information for Dundee Corporation Class A Subordinate Voting Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Dundee Corporation Class A Subordinate Voting Shares

Dundee Global Fund Corporation Announces Name Change of Mutual Fund Class
Dundee Corporation Renews Normal Course Issuer Bids on Three Share Classes
Dundee Corporation Holds the Line on Cost Reduction, Announces Fourth Quarter and Year-End Results
Dundee Corporation Declares Quarterly First Preference Shares, Series 3 Dividend
Dundee Corporation Declares Quarterly First Preference Shares, Series 2 Dividend
Dundee Corporation Announces Results of Substantial Issuer Bid for Its Series 3 Preferred Shares
Dundee Corporation Announces Intention to Commence a Substantial Issuer Bid for Up to C$20,000,005 in Value of its Series 3 Preferred Shares
Dundee Corporation Maintains Steady Course on Cost Reduction, Reports Third Quarter 2023 Financial Results and Announces Changes to the Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.